Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study
Archives of Medical Science – Atherosclerotic Diseases · 22.05.2020 · 5 (1) · 64-71
DOI: 10.5114/amsad.2020.95569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 22.05.2020. Verfasst von Stefania E Makariou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Health, Medical School, University of Ioannina, Ioannina, Greece. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Obesity is associated with cardiovascular disease (CVD) risk factors as well as decreased 25(OH) vitamin D serum levels. We aimed to study 25(OH) vitamin D levels in adolescents with obesity compared with normal weight controls in association with CVD risk factors, and the possible effect of vitamin D supplementation. Material and methods In a cross-sectional study, 69 obese and 34 normal-weight adolescents were included. In an interventional study 15 adolescents with obesity and vitamin D insufficiency were given 2000 IU vitamin D per os daily for 3 months.
Results
Adolescents with obesity had significantly lower 25(OH) vitamin D levels compared with normal-weight controls (12.0 (3.0–36.0) vs. 34.0 (10.0–69.0) ng/ml, respectively, p < 0.001). In adolescents with obesity, 25(OH) vitamin D was inversely associated with leptin even after adjustment for body mass index (BMI) (r = –0.340, p = 0.009). Conversely, 25(OH) vitamin D was not related with other parameters, such as BMI, blood pressure, lipids, glucose, insulin, homeostasis model assessment (HOMA) index, adiponectin, leptin/adiponectin ratio, and visfatin levels. Following supplementation in 15 vitamin D insufficient adolescents with obesity, 25(OH) vitamin D significantly increased (from 17.3 (12.5–27.8) to 32.6 (14.3–68.0) ng/ml, p = 0.005) and so did low-density lipoprotein cholesterol (LDL-C) (from 85.4 ±9.5 to 92.1 ±15.8 mg/dl, p = 0.022), while there were reductions in glycated haemoglobin (HbA1c) (from 5.8 ±0.2 to 5.5 ±0.1%, p = 0.03) and leptin (from 19.7 (7.8–45.5) to 15.1 (4.3–37.3) ng/ml, p = 0.03). Oxidised LDL, paraoxonase, arylesterase, and urine isoprostanes remained unchanged.
Conclusions
Adolescents with obesity had lower 25(OH) vitamin D, which may be associated with higher leptin levels. Vitamin D supplementation may lead to HbA1c and leptin reductions, but also to an increase in LDL-C.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child Health, Medical School, University of Ioannina, Ioannina, Greece.
- Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece.
- Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
Zitieren
APA
Makariou, S. E., Challa, A., Siomou, E., Tellis, C., Tselepis, A., Elisaf, M., & Liberopoulos, E. (2020). Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study. Archives of Medical Science – Atherosclerotic Diseases, 5(1), 64-71. https://doi.org/10.5114/amsad.2020.95569
Vancouver
Makariou SE, Challa A, Siomou E, Tellis C, Tselepis A, Elisaf M, et al. Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study. Archives of Medical Science – Atherosclerotic Diseases. 2020;5(1):64-71. doi:10.5114/amsad.2020.95569
BibTeX
@article{Makariou2020,
author = {Makariou, Stefania E and Challa, Anna and Siomou, Ekaterini and Tellis, Constantinos and Tselepis, Alexandros and Elisaf, Moses and Liberopoulos, Evangelos},
title = {Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study},
journal = {Archives of Medical Science – Atherosclerotic Diseases},
year = {2020},
volume = {5},
number = {1},
pages = {64--71},
doi = {10.5114/amsad.2020.95569}
}
EUVIMED